reference/32526320

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32526320

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	5415
issn	0732-183X 1527-7755
issueIdentifier	33
pageRange	5407-5415
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	5407
bibliographicCitation	Heymach JV, Paz-Ares L, De Braud F, Sebastian M, Stewart DJ, Eberhardt WE, Ranade AA, Cohen G, Trigo JM, Sandler AB, Bonomi PD, Herbst RS, Krebs AD, Vasselli J, Johnson BE. Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer. J Clin Oncol. 2008 Nov 20;26(33):5407–15. doi: 10.1200/jco.2008.17.3138. PMID: 18936474.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c31d46b94fd7d3cdef68d1e1ef029220 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82aabc45e795d125021b230af767b2cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44fc79264161374e851c693a07524341 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fa2b619bc0945ddba623e735d599ddb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_213d4ee641d9a2225ea40ce57e231a8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f96fb2495af142eab4525594a19c73d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a31f0418368d2ac2ff6640c1b333d53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a48a4a98bd1e6e58ffdb94957568be23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0103-730X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9868f73ef433815d50e00ed94789f734 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee1e6a5cab99aefd5254e99bbe54a2dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91e18dcce49ffb7ba77a0ebf8ee09a0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2597536e71ee67a0697ac1721de8abf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_988730eb3e8709d7d6096045bf3929d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa5e1c1cedca68a76892f1af73121277 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5be7adfdad7b552c2c84e8de9643c812
date	2008-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2008.17.3138 https://pubmed.ncbi.nlm.nih.gov/18936474
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
discusses	http://id.nlm.nih.gov/mesh/M0024707 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0356369 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0421253
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D011799Q000008 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D042461Q000037 http://id.nlm.nih.gov/mesh/D010880Q000008 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D010880Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011799Q000009 http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016190Q000008 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247533733

Total number of triples: 70.